Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $8.69B.
ENTERPRISE VALUE (EV)
$8.69B
Cytokinetics, Incorporated
Market Cap
$7.66B
Enterprise Value (EV)
$8.69B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Cytokinetics, Incorporated (CYTK) | $7.66B | $8.69B |
| HealthEquity, Inc. (HQY)vs › | $7.58B | $8.30B |
| Hinge Health, Inc. (HNGE)vs › | $7.52B | $7.24B |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.27B | $9.34B |
| Caris Life Sciences, Inc. (CAI)vs › | $8.18B | $7.94B |
| Alkermes plc (ALKS)vs › | $6.95B | $8.01B |
| Kymera Therapeutics, Inc. (KYMR)vs › | $8.40B | $8.36B |
| Oscar Health, Inc. (OSCR)vs › | $8.46B | $4.82B |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.57B | $9.38B |
| Chemed Corporation (CHE)vs › | $6.67B | $6.96B |
Market Cap
$7.66B
Total Debt
$1.16B
Cash
$122.52M
Enterprise Value
$8.69B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
